Novartis Institutes for BioMedical Research, 181 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.
PeptiDream, Inc., 3-25-23 Tonomachi, Kawasaki-Ku, Kawasaki, Kanagawa 210-0821, Japan.
J Med Chem. 2021 Mar 11;64(5):2622-2633. doi: 10.1021/acs.jmedchem.0c01505. Epub 2021 Feb 25.
Advances in the design of permeable peptides and in the synthesis of large arrays of macrocyclic peptides with diverse amino acids have evolved on parallel but independent tracks. Less precedent combines their respective attributes, thereby limiting the potential to identify permeable peptide ligands for key targets. Herein, we present novel 6-, 7-, and 8-mer cyclic peptides (MW 774-1076 g·mol) with passive permeability and oral exposure that feature the amino acids and thioether ring-closing common to large array formats, including DNA- and RNA-templated synthesis. Each oral peptide herein, selected from virtual libraries of partially N-methylated peptides using methods, reflects the subset consistent with low energy conformations, low desolvation penalties, and passive permeability. We envision that, by retaining the backbone N-methylation pattern and consequent bias toward permeability, one can generate large peptide arrays with sufficient side chain diversity to identify permeability-biased ligands to a variety of protein targets.
在透皮肽的设计和具有各种氨基酸的大环肽的大量合成方面的进展是在平行但独立的轨道上发展起来的。较少的先例结合了它们各自的属性,从而限制了识别关键靶标透皮肽配体的潜力。在此,我们提出了新的 6、7 和 8 个氨基酸的环肽(MW 774-1076 g·mol),具有被动通透性和口服暴露的特点,这些特性包括与大阵列格式(包括 DNA 和 RNA 模板合成)共同的氨基酸和硫醚环封闭。本文中选择的每个口服肽都是使用方法从部分 N-甲基化肽的虚拟文库中选择的,反映了与低能量构象、低去溶剂化罚分和被动通透性一致的亚集。我们设想,通过保留骨架 N-甲基化模式和随之而来的通透性偏向,可以生成具有足够侧链多样性的大肽阵列,以鉴定各种蛋白质靶标的通透性偏向配体。